Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Young Jun | - |
dc.contributor.author | Min, Junhong | - |
dc.date.accessioned | 2024-01-09T16:04:45Z | - |
dc.date.available | 2024-01-09T16:04:45Z | - |
dc.date.issued | 2024-04 | - |
dc.identifier.issn | 1618-2642 | - |
dc.identifier.issn | 1618-2650 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/70729 | - |
dc.description.abstract | Liquid biopsy, which promises noninvasive detection of tumor-derived material, has recently been highlighted because of its potential to lead us to an era of precision medicine. However, its development has encountered challenges owing to the extremely low frequency and low purity of circulating tumor markers, such as circulating tumor cells (CTCs), circulating exosomes, and circulating tumor nucleic acids (ctNAs). Much effort has been made to overcome this limitation over the last decade, and an increasing number of studies have shown interest in the special characteristics of hydrogels. This hydrophilic and biocompatible polymeric network, which absorbs a large amount of water, can aid in the isolation, protection, and analysis of these low-abundance and short-lived circulating biomarkers. The role of hydrogels in liquid biopsy is extensive and ranges from enrichment to encapsulation. This review provides an overview of hydrogel-based technologies to pave the way in liquid biopsy. © 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature. | - |
dc.format.extent | 14 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Science and Business Media Deutschland GmbH | - |
dc.title | Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s00216-023-05025-7 | - |
dc.identifier.bibliographicCitation | Analytical and Bioanalytical Chemistry, v.416, no.9, pp 2065 - 2078 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 001101448100001 | - |
dc.identifier.scopusid | 2-s2.0-85176549996 | - |
dc.citation.endPage | 2078 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 2065 | - |
dc.citation.title | Analytical and Bioanalytical Chemistry | - |
dc.citation.volume | 416 | - |
dc.type.docType | Article | - |
dc.publisher.location | 독일 | - |
dc.subject.keywordAuthor | Circulating tumor DNAs | - |
dc.subject.keywordAuthor | Circulating tumor markers | - |
dc.subject.keywordAuthor | Circulating tumor markers | - |
dc.subject.keywordAuthor | Exosomes | - |
dc.subject.keywordAuthor | Hydrogel | - |
dc.subject.keywordAuthor | Liquid biopsy | - |
dc.subject.keywordPlus | TUMOR-CELLS | - |
dc.subject.keywordPlus | EXTRACELLULAR VESICLES | - |
dc.subject.keywordPlus | CANCER-PATIENTS | - |
dc.subject.keywordPlus | FUNCTIONALIZED HYDROGEL | - |
dc.subject.keywordPlus | RESPONSIVE POLYMERS | - |
dc.subject.keywordPlus | NUCLEIC-ACIDS | - |
dc.subject.keywordPlus | DNA | - |
dc.subject.keywordPlus | EXOSOMES | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | BIOLOGY | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.